430 related articles for article (PubMed ID: 12744473)
1. Changing patterns in the neuropathogenesis of HIV during the HAART era.
Langford TD; Letendre SL; Larrea GJ; Masliah E
Brain Pathol; 2003 Apr; 13(2):195-210. PubMed ID: 12744473
[TBL] [Abstract][Full Text] [Related]
2. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.
Neuenburg JK; Brodt HR; Herndier BG; Bickel M; Bacchetti P; Price RW; Grant RM; Schlote W
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):171-7. PubMed ID: 12394795
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
4. The changing pattern of HIV neuropathology in the HAART era.
Gray F; Chrétien F; Vallat-Decouvelaere AV; Scaravilli F
J Neuropathol Exp Neurol; 2003 May; 62(5):429-40. PubMed ID: 12769183
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
6. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
7. HIV-1/AIDS neuropathology in a Canadian teaching centre.
Walsh K; Thompson W; Megyesi J; Wiley CA; Hammond R
Can J Neurol Sci; 2004 May; 31(2):235-41. PubMed ID: 15198450
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
Tan IL; McArthur JC
Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
[No Abstract] [Full Text] [Related]
9. [The neuropathology of HIV infection in the era of highly active antiretroviral therapy].
Vallat-Decouvelaere AV; Chrétien F; Lorin de la Grandmaison G; Carlier R; Force G; Gray F
Ann Pathol; 2003 Oct; 23(5):408-23. PubMed ID: 14752384
[TBL] [Abstract][Full Text] [Related]
10. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience.
Oliveira JF; Greco DB; Oliveira GC; Christo PP; Guimarães MD; Oliveira RC
Rev Soc Bras Med Trop; 2006; 39(2):146-51. PubMed ID: 16699639
[TBL] [Abstract][Full Text] [Related]
11. [HIV and the central nervous system].
Moulignier A
Rev Neurol (Paris); 2006 Jan; 162(1):22-42. PubMed ID: 16446621
[TBL] [Abstract][Full Text] [Related]
12. Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies.
Vago L; Bonetto S; Nebuloni M; Duca P; Carsana L; Zerbi P; D'Arminio-Monforte A
AIDS; 2002 Sep; 16(14):1925-8. PubMed ID: 12351952
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.
Manzardo C; Del Mar Ortega M; Sued O; García F; Moreno A; Miró JM
J Neurovirol; 2005; 11 Suppl 3():72-82. PubMed ID: 16540459
[TBL] [Abstract][Full Text] [Related]
16. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
17. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy.
Langford TD; Letendre SL; Marcotte TD; Ellis RJ; McCutchan JA; Grant I; Mallory ME; Hansen LA; Archibald S; Jernigan T; Masliah E;
AIDS; 2002 May; 16(7):1019-29. PubMed ID: 11953468
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.
; Garvey L; Winston A; Walsh J; Post F; Porter K; Gazzard B; Fisher M; Leen C; Pillay D; Hill T; Johnson M; Gilson R; Anderson J; Easterbrook P; Bansi L; Orkin C; Ainsworth J; Phillips AN; Sabin CA
Eur J Neurol; 2011 Mar; 18(3):527-34. PubMed ID: 21159073
[TBL] [Abstract][Full Text] [Related]
19. Neurologic and psychiatric complications of antiretroviral agents.
Raines C; Radcliffe O; Treisman GJ
J Assoc Nurses AIDS Care; 2005; 16(5):35-48. PubMed ID: 16433108
[TBL] [Abstract][Full Text] [Related]
20. The changing role of HIV-associated oral candidiasis in the era of HAART.
Patuwo C; Young K; Lin M; Pardi V; Murata RM
J Calif Dent Assoc; 2015 Feb; 43(2):87-92. PubMed ID: 25868223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
